Advancing the Reality of Using Biomarker-Driven Endpoints to Demonstrate Improvements in Cognitive Function & Behaviour
Time: 12:30 pm
day: Conference Day Two - Track Three
Details:
- Exploring progress in biomarker assays and remote data collection
- Outlining the key characteristics for selecting the most suitable assay, and at what cut off, to be used as evidence
- Reviewing the evolving regulatory guidance on the use of these assays
